These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26112529)

  • 1. [Neonatal screening for severe combined immunodeficiency: the DEPISTREC study].
    Thomas C; Mirallié S; Audrain M; Dert C;
    Arch Pediatr; 2015 May; 22(5 Suppl 1):73-4. PubMed ID: 26112529
    [No Abstract]   [Full Text] [Related]  

  • 2. Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: Analysis of cost-effectiveness based on French real field data.
    Clément MC; Mahlaoui N; Mignot C; Le Bihan C; Rabetrano H; Hoang L; Neven B; Moshous D; Cavazzana M; Blanche S; Fischer A; Audrain M; Durand-Zaleski I
    J Allergy Clin Immunol; 2015 Jun; 135(6):1589-93. PubMed ID: 25840725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and economic aspects of newborn screening for severe combined immunodeficiency: DEPISTREC study results.
    Thomas C; Durand-Zaleski I; Frenkiel J; Mirallié S; Léger A; Cheillan D; Picard C; Mahlaoui N; Riche VP; Roussey M; Sébille V; Rabetrano H; Dert C; Fischer A; Audrain M
    Clin Immunol; 2019 May; 202():33-39. PubMed ID: 30946917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the T-cell receptor excision circle assay performances for severe combined immunodeficiency neonatal screening on Guthrie cards in a French single centre study.
    Audrain M; Thomas C; Mirallie S; Bourgeois N; Sebille V; Rabetrano H; Durand-Zaleski I; Boisson R; Persyn M; Pierres C; Mahlaoui N; Fischer A
    Clin Immunol; 2014 Feb; 150(2):137-9. PubMed ID: 24412905
    [No Abstract]   [Full Text] [Related]  

  • 5. Newborn Screening for Severe Combined Immunodeficiency: Analytic and Clinical Performance of the T Cell Receptor Excision Circle Assay in France (DEPISTREC Study).
    Audrain MAP; Léger AJC; Hémont CAF; Mirallié SM; Cheillan D; Rimbert MGM; Le Thuaut AM; Sébille-Rivain VA; Prat A; Pinel EMQ; Divry E; Dert CGL; Fournier MAG; Thomas CJC
    J Clin Immunol; 2018 Oct; 38(7):778-786. PubMed ID: 30251145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs associated with treatment of severe combined immunodeficiency-rationale for newborn screening in Sweden.
    Gardulf A; Winiarski J; Thorin M; Heibert Arnlind M; von Döbeln U; Hammarström L
    J Allergy Clin Immunol; 2017 May; 139(5):1713-1716.e6. PubMed ID: 28012934
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of newborn screening for severe combined immunodeficiency.
    Van der Ploeg CPB; Blom M; Bredius RGM; van der Burg M; Schielen PCJI; Verkerk PH; Van den Akker-van Marle ME
    Eur J Pediatr; 2019 May; 178(5):721-729. PubMed ID: 30805731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neonatal screening of severe combined immunodeficiencies].
    Thomas C; Mirallié S; Pierres C; Dert C; Clément MC; Mahlaoui N; Durand-Zaleski I; Fischer A; Audrain M;
    Arch Pediatr; 2015 Jun; 22(6):646-52. PubMed ID: 25896629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State.
    Ding Y; Thompson JD; Kobrynski L; Ojodu J; Zarbalian G; Grosse SD
    J Pediatr; 2016 May; 172():127-35. PubMed ID: 26876279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State, federal efforts under way to identify children with "bubble boy syndrome".
    Kuehn BM
    JAMA; 2010 Oct; 304(16):1771-3. PubMed ID: 20978250
    [No Abstract]   [Full Text] [Related]  

  • 11. Newborn screening for severe combined immunodeficiency does not identify bare lymphocyte syndrome.
    Kuo CY; Chase J; Garcia Lloret M; Stiehm ER; Moore T; Aguilera MJ; Lopez Siles J; Church JA
    J Allergy Clin Immunol; 2013 Jun; 131(6):1693-5. PubMed ID: 23453137
    [No Abstract]   [Full Text] [Related]  

  • 12. Newborn screening for severe combined immune deficiency (technical and political aspects).
    Kobrynski L
    Curr Opin Allergy Clin Immunol; 2015 Dec; 15(6):539-46. PubMed ID: 26485096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an infant with severe combined immunodeficiency by newborn screening.
    Hale JE; Bonilla FA; Pai SY; Gerstel-Thompson JL; Notarangelo LD; Eaton RB; Comeau AM
    J Allergy Clin Immunol; 2010 Nov; 126(5):1073-4. PubMed ID: 20933257
    [No Abstract]   [Full Text] [Related]  

  • 14. Newborn screening for SCID: where are we now?
    Buelow BJ; Routes JM; Verbsky JW
    Expert Rev Clin Immunol; 2014 Dec; 10(12):1649-57. PubMed ID: 25387596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential costs and benefits of newborn screening for severe combined immunodeficiency.
    McGhee SA; Stiehm ER; McCabe ER
    J Pediatr; 2005 Nov; 147(5):603-8. PubMed ID: 16291349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency.
    Lipstein EA; Vorono S; Browning MF; Green NS; Kemper AR; Knapp AA; Prosser LA; Perrin JM
    Pediatrics; 2010 May; 125(5):e1226-35. PubMed ID: 20403930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn Screening for Severe Combined Immunodeficiency: Changing the Landscape of Pediatric Primary Immunodeficiencies.
    Nickels AS; Abraham RS
    J Allergy Clin Immunol Pract; 2015; 3(6):1008-9. PubMed ID: 26866067
    [No Abstract]   [Full Text] [Related]  

  • 18. Neonatal screening for severe combined immune deficiency.
    Puck JM
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):522-7. PubMed ID: 17989529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extending neonatal screening to the detection of severe combined immunodeficiencies. A moral imperative].
    Alsina L; Llobet-Agulló P; Soler-Palacín P
    An Pediatr (Barc); 2014 Nov; 81(5):273-4. PubMed ID: 25239886
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of a false-positive screen for severe combined immunodeficiency in Pennsylvania, a state without statewide screening.
    Rosenberg S; Ikeda MD; Chong HJ
    J Allergy Clin Immunol Pract; 2013; 1(4):407-8. PubMed ID: 24565549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.